Perspectives on DNA vaccines. Targeting staphylococcal adhesins to prevent implant infections

Carla Renata Arciola, Pietro Speziale, Lucio Montanaro

Research output: Contribution to journalArticlepeer-review

Abstract

DNA vaccines consist of a plasmid DNA genetically engineered to produce one or more proteins able to elicit protective immune responses against virulence factors of infectious pathogens. Once introduced into the cells of the host, a DNA vaccine induces a high production of antigens by the endogenous presence of the peptide codifying gene; improves antigen processing and presentation; may be able to simultaneously co-express multiple antigenic molecules; and, lastly, switches on both humoral and cellular immune responses. In this mini-review, we underscore the advantageous characteristics of DNA vaccines compared with traditional ones and provide summaries of some of the more recent studies on them, mainly focusing the possibility of their use in targeting the staphylococcal adhesins that play a key role in the first adhesive phase of implant infections.

Original languageEnglish
Pages (from-to)635-641
Number of pages7
JournalInternational Journal of Artificial Organs
Volume32
Issue number9
Publication statusPublished - 2009

Keywords

  • Adhesins
  • DNA vaccines
  • Implant infections
  • MSCRAMMs
  • Staphylococcus aureus

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering
  • Bioengineering
  • Medicine (miscellaneous)

Fingerprint Dive into the research topics of 'Perspectives on DNA vaccines. Targeting staphylococcal adhesins to prevent implant infections'. Together they form a unique fingerprint.

Cite this